ANDA 218140, held by Gland. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 218140 (Vancomycin Hydrochloride), held by Gland, was first approved by FDA on Mar 21, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 21, 2025 | Original application | Approved | None posted |
| Vancomycin HydrochlorideEQ 750MG BASE/VIAL · powder;intravenous | Vancomycin Hydrochloride | Rx |
| Vancomycin HydrochlorideEQ 1.25GM BASE/VIAL · powder;intravenous | Vancomycin Hydrochloride | Rx |
| Vancomycin HydrochlorideEQ 1.5GM BASE/VIAL · powder;intravenous | Vancomycin Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters